Three basic patterns of peptidoglycan (PG) synthesis have emerged from the study of rod-shaped (bacillus), spherical (coccus), and ellipsoid (ovococcus) bacteria (reviewed in references 12, 71, and 72). In rod-shaped bacteria, like Escherichia coli, Bacillus subtilis, and Caulobacter crescentus, PG synthesis occurs at two locations catalyzed by distinct sets of proteins (12, 35, 36, 71) . Lateral PG synthesis elongates the side walls of these bacteria and results in their rod shape (12, 35, 71) . Lateral PG synthesis is mediated by actin-like MreB paralogue proteins, which form filamentous helical structures in spirals over the length of cells (12, 35, 66) . MreB is thought to organize the MreC and MreD proteins, which in turn recruit specific penicillin-binding proteins (PBPs) and other division proteins that catalyze lateral PG formation (26, 54, 55, 70) . Septal PG synthesis is organized by FtsZ ring formation, followed by the orderly assembly of the divisome complex, which includes a set of PBPs different from those involved in lateral PG synthesis (16, 22, 23) . The mutational interruption of lateral or septal PG synthesis of rod-shaped bacteria generally results in the formation of spherical or elongated cells, respectively (3, 4, 9, 31). Although useful, this two-state model is obviously an oversimplification (35), and recent results reveal that MreB, MreC, MreD, and specific PBPs also form annular rings adjacent to FtsZ rings at the septa of dividing E. coli cells (67). Moreover, some PBPs and division regulators, such as PBP1 and GpsB of B. subtilis, shuttle between the lateral and septal PG synthesis machineries (9).
Three basic patterns of peptidoglycan (PG) synthesis have emerged from the study of rod-shaped (bacillus), spherical (coccus), and ellipsoid (ovococcus) bacteria (reviewed in references 12, 71, and 72). In rod-shaped bacteria, like Escherichia coli, Bacillus subtilis, and Caulobacter crescentus, PG synthesis occurs at two locations catalyzed by distinct sets of proteins (12, 35, 36, 71) . Lateral PG synthesis elongates the side walls of these bacteria and results in their rod shape (12, 35, 71) . Lateral PG synthesis is mediated by actin-like MreB paralogue proteins, which form filamentous helical structures in spirals over the length of cells (12, 35, 66) . MreB is thought to organize the MreC and MreD proteins, which in turn recruit specific penicillin-binding proteins (PBPs) and other division proteins that catalyze lateral PG formation (26, 54, 55, 70) . Septal PG synthesis is organized by FtsZ ring formation, followed by the orderly assembly of the divisome complex, which includes a set of PBPs different from those involved in lateral PG synthesis (16, 22, 23) . The mutational interruption of lateral or septal PG synthesis of rod-shaped bacteria generally results in the formation of spherical or elongated cells, respectively (3, 4, 9, 31) . Although useful, this two-state model is obviously an oversimplification (35) , and recent results reveal that MreB, MreC, MreD, and specific PBPs also form annular rings adjacent to FtsZ rings at the septa of dividing E. coli cells (67) . Moreover, some PBPs and division regulators, such as PBP1 and GpsB of B. subtilis, shuttle between the lateral and septal PG synthesis machineries (9) .
Much less is known about the mechanisms of PG synthesis in coccus and ovococcus species. In spherical species, such as Staphylococcus aureus, only a septal PG synthesis machinery seems to be present (20, 47, 72) , although S. aureus still encodes homologues of proteins like MreC and MreD that mediate lateral PG synthesis in rod-shaped bacteria (35) . In contrast, ovococcus species, such as Streptococcus pneumoniae and Lactococcus lactis, form American football-shaped cells by a combination of peripheral sidewall and septal PG synthesis that occurs in the midcell regions of dividing cells ( Fig. 1) (11, 42) . Ovococcus species lack an MreB homologue, and peripheral and septal PG synthesis are likely coordinated with and organized by FtsZ ring formation (64, 65, 72) . Because two modes of PG biosynthesis are required to form ellipsoidshaped bacteria, models have been proposed for two different PG synthesis machineries (18, 21, 33, 72) . Based on the composition of the complexes in rod-shaped cells, it has been hypothesized that specific sets of homologous cell division proteins mediate peripheral (MreC, MreD, RodA, and PBP2b) and septal (FtsZ, EzrA, PBP2x, FtsW, and DivIB/FtsL/DivIC) PG synthesis in ovococcus bacteria (72) . A recent study correlating the effects of mutations or antibiotic treatments to changes in cell shapes supports the idea that the PBP2x and PBP2b class B transpeptidases are associated with septal and peripheral PG synthesis, respectively, in L. lactis (46) and provides some of the first direct evidence for a two-state model in ovococci. However, most other aspects of this model are largely untested, and it remains to be determined whether the two ovococcus PG synthesis machineries exist as two distinct complexes ( Fig. 1 ) or form one large complex at midcell (72) . In addition, the roles of class A (dual-function transglycosylase-transpeptidase) PBP1a, PBP1b, and PBP2a are unknown.
In this paper, we report the first characterization and localization of the MreC and MreD proteins in a coccus or ovococcus species. In rod-shaped bacteria, MreC and MreD are essential proteins that play crucial roles in lateral PG synthesis (3, 5, 15, 27, 31) . The genes encoding MreC and MreD are cotranscribed with that encoding MreB (17) , and all three Mre proteins are involved in organizing the helical insertion of new PG during sidewall elongation (13, 31, 70) . The exact functions of MreC and MreD remain unknown. MreC consists of three domains: a cytoplasmic amino-terminal tail, a membrane-spanning domain, and an extracytoplasmic coiled-coil domain required for self dimerization (62) . MreD is an integral membrane protein with five membrane-spanning domains (27, 31) . The depletion of MreC or MreD in rod-shaped bacteria leads to the formation of spherical cells and eventual lysis (3, 27, 31) . Fractionation and two-hybrid analyses demonstrated that E. coli and B. subtilis MreC are in the cell membrane, where they interact with MreD (28, 62) . MreC has been shown to interact with multiple PBPs in C. crescentus and B. subtilis (13, 62) . In E. coli, C. crescentus, and B. subtilis, MreC localizes helically along the cylindrical walls of cells (15, 31, 67) . In E. coli and B. subtilis, the helical sidewall localization of MreC is organized by MreB family proteins (4, 25, 26, 58, 66) , whereas the migration of MreC to the paraseptal rings adjacent to the FtsZ ring of dividing E. coli cells is independent of MreB or MreD (67) . In contrast to E. coli and B. subtilis, the helical filament formation of MreC is independent of MreB in C. crescentus, where MreC is located detached from the inner membrane in the periplasm (15) .
In ovococcus species that produce MreC and MreD, such as Streptococcus pneumoniae, Streptococcus mitis, Streptococcus mutans, Streptococcus thermophilus, Lactococcus lactis, and Enterococcus faecalis, the mreCD genes are always located immediately upstream of the pcsB gene, which plays roles in cell division and PG biosynthesis (L.-T. Sham, unpublished data) (1, 19, 42, 43) . pcsB is essential in serotype 2 strains of S. pneumoniae but essentiality can be masked by the accumulation of different kinds of bypass suppressor mutations (S. M. Barendt, unpublished data) (1). Curiously, several important ovococcus species, including Streptococcus pyogenes (group A Streptococcus) and Streptococcus agalactiae (group B Streptococcus), do not encode identifiable homologues of MreC and MreD (72) . Previously, we reported that MreC and MreD were not essential in the R6 laboratory strain of S. pneumoniae (1) . Further experiments reported here for the prototypical virulent serotype 2 strain D39 show that MreC and MreD are indeed essential and likely play roles in peripheral PG synthesis in pneumococcus. We show that the ability to knock out the mreCD genes in the R6 and D39 backgrounds is due to the accumulation of suppressor mutations, including inactivation or knockout mutations in the pbp1a gene, which encodes a major class A PBP that influences the diameter of pneumococcal cells. Finally, we show that MreC and MreD localize to the equators and septa of dividing pneumococcal cells. We were unable to detect strong filament formation of the type observed in rod-shaped bacteria.
MATERIALS AND METHODS
Bacterial strains and growth conditions. Bacterial strains used in this study were derived from S. pneumoniae serotype 2 strain D39 and its unencapsulated laboratory strain derivative R6 (30) (see Table S1 and Fig. S1 in the supplemental material). Bacteria were grown on plates containing Trypticase soy agar II (modified; Becton-Dickinson) and 5% (vol/vol) defibrinated sheep blood (TSAII-BA) and incubated at 37°C in an atmosphere of 5% CO 2 . Strains were cultured statically in Becton-Dickinson brain heart infusion (BHI) broth at 37°C in an atmosphere of 5% CO 2 , and growth was monitored by optical density at 620 nm (OD 620 ) using a Spectronic 20 spectrophotometer fitted for the measurement of capped tubes (outer diameter, 16 mm). Bacteria were inoculated into BHI broth from frozen cultures or colonies, serially diluted into the same medium, and propagated overnight. Overnight cultures that were still in exponential phase (OD 620 of 0.1 to 0.6) were diluted back to an OD 620 of 0.005 to start final experimental cultures, which did not contain antibiotics. Overnight cultures of strains containing genes fused to the inducible P fcsK promoter (6) contained 0.2 to 0.8% (wt/vol) L-fucose. Cells from these overnight cultures were collected by centrifugation (10 min at 3,200 ϫ g at 25°C), washed twice in BHI broth lacking L-fucose, and suspended in fresh BHI broth containing (0.2 to 0.8% [wt/vol]) or lacking L-fucose. Sensitivity to penicillin G was determined as described previously (1) .
Construction and verification of mutants. Strains containing antibiotic markers were constructed by transforming linear DNA amplicons synthesized by overlapping fusion PCR into competent pneumococcal cells as described previously (43, 49, 51, 53) . Primers synthesized for this study are listed in Table S2 in the supplemental material. Transformations were carried out as described before (2) . TSAII-BA plates were supplemented, as appropriate, with the following final concentrations of antibiotics: 250 g kanamycin per ml, 150 g spectinomycin per ml, 0.3 g erythromycin per ml, or 200 g streptomycin per ml. All constructs were confirmed by PCR, where reaction mixtures contained genomic DNA prepared from cell lysates (2) , and by DNA sequencing. Amplicons containing these mutations were purified using a PCR cleanup kit (Qiagen) and sequenced FIG. 1. Two-state model of PG biosynthesis in ovococcus bacteria, such as S. pneumoniae. To attain an ellipsoid shape, two machineries have been proposed that carry out peripheral and septal PG synthesis (12, 71, 72) . At the start of a division cycle, components of both machines locate to the equators of cells (bottom). One machine (orange dots) carries out peripheral PG synthesis (light blue; top) between the future equator and septum of dividing cells. Peripheral PG synthesis corresponds to a form of lateral (sidewall) PG synthesis in rod-shaped bacteria. At some point, septal PG synthesis (medium blue; green dots) commences to divide the cell in two. For clarity, the peripheral and septal machines are shown at separate locations at the middle of dividing cells, although the spatial locations and compositions of the two machines have not been established (12, 72) . The red dot corresponds to PG hydrolases that remodel the PG and allow septal separation. See the text for additional details.
in reaction mixtures containing 1 l of BigDye Terminator reagent (Applied Biosystems) as described previously (30) . Sequences were aligned and analyzed using Vector NTI software (Invitrogen).
Mapping of ⌬mreCD suppressor mutations by whole-genome sequencing. D39 strains IU3897 and IU3898 containing suppressor mutations that allowed the growth of a ⌬mreCD deletion mutant were isolated as described in Results. Overnight cultures still in exponential phase (see above) were diluted into 30 ml of BHI broth in 50-ml conical tubes to an OD 620 of Ϸ0.001 and grown to an OD 620 of Ϸ0.050. Cells were collected by centrifugation (10,000 ϫ g for 10 min at 4°C). Genomic DNA was purified from collected cells using a MasterPure Gram-positive DNA purification kit (Epicenter Biotechnologies) according to the manufacturer's protocol. Five g of purified genomic DNA from each strain was used to construct a genomic library for single-end-read Illumina DNA sequencing as described by Lazinski and Camilli (http://www.tucf.org/htseq _protocol_for_illumina_paired.pdf). DNA from IU3897 and IU3898 was tagged with bar-coded adapters Illumina bar 1A and Illumina bar 1B, respectively (see Table S2 in the supplemental material). Illumina DNA sequencing in a singlelane run was performed by the Tufts University Core Facility, which assembled the sequences based on the published D39 genome sequence (30) and performed bioinformatic analyses. Full coverage was obtained for the genomes of each mutant with Ͼ200 reads of most base pairs and only one small gap in one mutant.
Reverse transcription-PCR (RT-PCR). Total pneumococcal RNA was purified as described previously (44) . To detect mreCD-pcsB cotranscripts, cDNA was synthesized from total RNA using primer WN212 (see Table S2 and Fig. S2 in the supplemental material) and the Stratascript first-strand synthesis kit according to the manufacturer's instructions. Cotranscripts were detected by PCR amplification in reaction mixtures containing rTth DNA polymerase (Applied Biosystems), synthesized cDNA, and primer pairs AL005/WN212, AL006/ WN212, and WN259/WN212 (see Table S2 and Fig. S2 ). PCR amplification reaction mixtures containing genomic DNA as the template or that omitted reverse transcriptase in the first step of the procedure were used as positive or negative controls, respectively.
Northern blotting. Total RNA was purified from pneumococcal strains as described previously (44) . Northern blots were performed using a Northern Max kit (Ambion). RNA Millennium size markers (Ambion) and 20 to 30 g of total RNA from the indicated strains were separated in individual lanes on denaturing 1% (wt/vol) agarose gels and transferred to Bright Star Plus positively charged nylon membranes (Ambion) according to the manufacturer's instructions. Primers MreC and PcsB (see Table S2 in the supplemental material) were end labeled using T4 polynucleotide kinase (New England BioLabs) and 1.67 pmol of [␥- 32 P]ATP (6,000 Ci per mmol; Perkin Elmer) and purified on Sephadex G-25 quick-spin columns (Roche). Radiolabeled probes were hybridized to blots in Ultrahyb-Oligo buffer (Ambion) according to the manufacturer's instructions. Labeled Northern blots were exposed to X-ray film to obtain images. Blots were stripped and hybridized with a radiolabeled probe specific for 5S RNA (see Table S2 ) to confirm the equal loading and transfer of RNA samples (61) .
Microscopy. Five hundred-l samples were taken from exponentially growing BHI broth cultures at an OD 620 of 0.1 to 0.2. Cells were collected by centrifugation in a microcentrifuge (21,000 ϫ g for 10 min at 25°C) and resuspended in 50 l of room-temperature BHI broth. Concentrated cells were stained without fixation by adding 4,6-diamidino-2-phenylindole (DAPI), a 1:1 mixture of vancomycin and Bodipy-FL-conjugated vancomycin (FL-V) (Molecular Probes), or FM-4-64 (Molecular Probes) to a final concentration of 0.2, 2, or 10 g per ml, respectively, as described previously (1). Cells were viewed using an epifluorescent microscope, and images were recorded as described before (1) . In control experiments, cells in exponential phase (OD 620 of 0.10 to 0.20) were examined without staining to ensure that cell morphology defects observed were not caused by the concentrations of vancomycin used for staining (data not shown). Lengthto-width aspect ratios (ARs) were determined from phase-contrast micrographs by using Nikon NIS-Elements AR software as described previously (1) .
Immunofluorescent microscopy (IFM) was performed to localize MreC and MreD in exponentially growing cells. MreC and MreD were tagged at their carboxyl termini with a peptide linker (L) followed by three tandem copies of the FLAG epitope tag (L-FLAG 3 ) as described previously for other proteins (2, 69) . The MreC-L-FLAG 3 and MreD-L-FLAG 3 proteins were expressed from their native chromosomal locus in unencapsulated laboratory strain R6 and in an unencapsulated derivative of strain D39 (strains IU3238, IU4868, and IU4970; see Table S1 in the supplemental material). IFM was performed using commercially available purified polyclonal anti-FLAG antibody (F7425; Sigma) exactly as described previously (2, 69) . Positive-control experiments showed the proper localization of FLAG-tagged FtsZ at equators and septa (69) , and negativecontrol experiments showed no detectable staining of bacteria that did not contain a FLAG-tagged protein (data not shown). Only single bands of the expected molecular masses were detected for MreC-L-FLAG 3 and MreD-L-FLAG 3 in Western blots (see below) probed with anti-FLAG antibody, indicating no significant cleavage of the tag from the fusion proteins.
Western blotting. The preparation of extracts for Western blotting was done in two ways, which gave comparable yields of the membrane-bound MreC and MreD proteins. For routine Western blotting, 1-ml samples of exponentially growing cultures at an OD 620 of Ϸ0.2 were microcentrifuged (21,000 ϫ g for 10 min at 25°C). Cell pellets were lysed directly by resuspension in 100 l of lysis buffer (1% [wt/vol] SDS, 0.1% [vol/vol] Triton X-100), and protein concentrations were determined using the DC protein assay (Bio-Rad). Eighty l of cell lysates was mixed with 80 l of 2ϫ SDS-PAGE sample buffer (Bio-Rad) containing freshly added 5% (vol/vol) ␤-mercaptoethanol and heated for 10 min at 95°C. Cell lysate samples usually containing 15 g of protein were resolved on 4% stacking-10% SDS-PAGE gels in Tris-glycine buffer as described before (69) . Electrophoresis, membrane transfer, and immunodetection using ECL chemiluminescent reagents were performed as described in reference 69. Bands on blots were detected by autoradiography on XAR film and quantitated by photonic imaging using an IVIS Xenogen VivoVision Lumina system and software as described before (69) .
Cellular amounts of MreC were determined by quantitative Western blotting in unencapsulated strain R6 as described previously (1, 69) . Briefly, 1.0-ml samples of the parent R6 strain (EL59) and an R6 ⌬mreCD mutant (IU1983) were taken from exponentially growing BHI broth cultures at an OD 620 of 0.2 to 0.3 and centrifuged (21,000 ϫ g for 10 min at 25°C). Pellets were suspended in 100 l of a lysis buffer containing 40 g mutanolysin per ml (69) and incubated at 37°C for 10 min. One hundred l of 2ϫ SDS sample buffer (Bio-Rad) containing 5% ␤-mercaptoethanol was added, and samples were incubated at 90°C for 8 min. Lysates were microcentrifuged (3,330 ϫ g for 3 min at 25°C), and 10 and 25 l of the supernatants were resolved by SDS-PAGE (1, 69). His 6 -(N)-MreC lacking a membrane domain was purified as a standard as described in reference 1. Standard curves for MreC quantification were generated by adding 0.0025 to 0.025 g of purified His 6 -(N)-MreC to 10 l of lysate of the R6 ⌬mreCD deletion mutant prior to loading onto SDS-PAGE gels. Proteins were transferred onto nitrocellulose membranes, and MreC protein was detected using polyclonal anti-MreC antibody as reported previously (1). Chemiluminescent detection and quantification were performed using an IVIS imaging system (see above) (1, 69) . CFU determinations of the R6 cultures used for lysate preparations were determined by serial dilution and plating onto TSAII-BA plates. Molecules per cell were calculated from CFU, taking into account that the unencapsulated R6 strain formed primarily diplococci and chains of two diplococci at a 3:1 ratio (data not shown), which means on average that each CFU corresponded to Ϸ2.3 cells.
RESULTS
Pneumococcal mreCD and pcsB are transcribed independently. To determine whether the conserved grouping of mreCD with pcsB implies cotranscription or regulation, we first performed RT-PCR on the mreCD-pcsB intercistronic region (see Materials and Methods and Fig. S2 in the supplemental material). Total RNA was prepared from laboratory strain R6 and virulent serotype 2 strain D39, including DNase treatment to remove contaminating genomic DNA. cDNA was generated by reverse transcription from reverse primer WN212, which anneals 198 nucleotides downstream from the pcsB start codon (see Fig. S2 ). This cDNA was used as the template in PCRs carried out using primer WN212 and forward primers annealing within mreC, mreD, or the mreD-pcsB intercistronic region (see Fig. S2 ). Reverse transcription-dependent amplification products were obtained with each primer pair, indicating the presence of a cotranscript extending at least from within mreC to pcsB (see Fig. S2 ).
However, Northern blots indicated considerable independent expression of pcsB. Northern analysis was performed using probes specific for mreC and pcsB ( Fig. 2A) . Total RNA was prepared from cultures of the parent R6 strain (EL59), an R6 ⌬mreCD mutant (IU1983), and a ⌬pcsB mutant containing a characterized bypass suppressor mutation (IU3363) (S. M. Barendt, unpublished) . For the parent and ⌬mreCD strains, hybridization with the pcsB-specific probe detected a Ϸ1.2-kb transcript ( Fig. 2B ) corresponding to the predicted size of a monocistronic pcsB transcript extending from the P pcsB promoter to a predicted factor-independent terminator downstream of pcsB ( Fig. 2A ). This pcsB transcript was absent from RNA from the ⌬pcsB bypass mutant (Fig. 2B) . No mreCDpcsB cotranscript was detected using the pcsB-specific probe (Fig. 2B) . The mreC-specific probe failed to detect any mreC transcripts, despite the presence of 5S rRNA on blots (data not shown). Thus, a considerable amount of pcsB transcript originating from the WalR Spn -dependent P pcsB promoter, but no mreCD or mreCD-pcsB cotranscript, was detected in Northern blots.
MreC and MreD are not essential in laboratory strain R6. R6 is a commonly used laboratory strain that is diplococcal due to the absence of capsule (1). R6 contains more than 70 additional drift mutations compared to its serotype 2 D39 progenitor strain (30) . We constructed deletion amplicons in which the mreC, mreD, or mreCD reading frames were replaced by the P c synthetic promoter driving an erm (erythromycin resistance) gene or by the promoterless in-frame add9 gene (spectinomycin resistance) ( Table 1 , rows 1, 4, 5, and 6; also see Table S1 in the supplemental material). Both types of mreCD insertion amplicons readily transformed the R6 strain and yielded large numbers of colonies characteristic of transformations of control amplicons containing the resistance markers in other genes (Table 1 , rows 2, 3, and 7). All transformants appeared after overnight incubations, and recovered ⌬mreCD, ⌬mreC, or ⌬mreD mutants grew like the R6 parent strain in culture and had normal cell morphology (Fig. 3A and C and data not shown). The R6 parent and ⌬mreCD mutants also responded similarly to stress responses, including high temperature (limit for growth on plates, 41.4°C) and sensitivity to 0.1 g penicillin G per ml (data not shown) (1, 61) .
We tested for suppressor accumulation during transformation with the ⌬mreCD amplicons. mreCD ϩ transcripts were expressed under the control of the fucose-inducible P fcsK promoter from the ectopic ⌬bgaAЈ locus (6, 52) . Quantitative RT-PCR and Western blotting confirmed that mreCD ϩ transcript and MreC protein were overexpressed by Ϸ5-fold or underexpressed by Ϸ2-fold from the ectopic site in the pres- The mapped P pcsB promoter, which is regulated by the WalRK Spn (VicRK) two-component regulatory system (44, 50) and putative factor-independent transcription terminators (lollipops), are indicated. The bars indicate positions of probes used in Northern blots. The stop codon of mreC overlaps the start codon of mreD by 1 bp; the intercistronic space between the stop codon of mreD and the start codon of pcsB is 93 bp and contains a putative transcription terminator ending 44 bp upstream from the pcsB start codon; the WalR Spn (VicR) response regulator binding site is 59 to 79 bp upstream of the pcsB start codon (44) ; the transcription start of the P pcsB promoter is a G residue 29 bp upstream of the pcsB start codon (L.-T. Sham, unpublished); the downstream putative transcription terminator starts 6 bp after the stop codon of pcsB. (B) Northern blots of total RNA extracted from the R6 parent strain (EL59), ⌬mreCD mutant IU1983, and a D39 ⌬pcsB mutant containing a defined suppressor mutation (S. M. Barendt, unpublished) . RNA was extracted from exponentially growing cells, and Northern blotting was performed as described in Materials and Methods. The positions of RNA standards are indicated. The upper panel shows a blot hybridized with the pcsB-specific probe. A single band was detected in R6 and ⌬mreCD lanes but not in the ⌬pcsB sup lane, with a size corresponding to a transcript extending from the P pcsB promoter to the terminator after pcsB. The lower panel shows the same blot stripped and reprobed for 5S rRNA, indicating approximately equal loading in all three lanes. Hybridization with the mreCspecific probe did not reveal an mreCD transcript (data not shown; see Discussion). The experiment was done three times independently with the same results. 1. ⌬mreCDϽϾP c -erm Ͼ500 Ͼ500 Ͻ20 Ͼ500 2. pcsB ϩ -P c -erm Ͼ500 Ͼ500 Ͼ500 Ͼ500 3. lctO::erm Ͼ500 NT b Ͼ500 NT 4. ⌬mreCDϽϾaad9 Ͼ500 Ͼ500 Ͻ20 Ͼ500 5. ⌬mreCϽϾaad9 Ͼ500 Ͼ500 Ͻ20 Ͼ500 6. ⌬mreDϽϾaad9 Ͼ500 Ͼ500 Ͻ20 Ͼ500 7. purR::aad9 Ͼ500 Ͼ500 Ͼ500 Ͼ500
a Unencapsulated pneumococcal strains R6 (EL59), R6 ⌬bgaAЈ::P fcsK -mreCD (IU2920), D39 ⌬cps (IU1945), and D39 ⌬cps ⌬bgaAЈ::P fcsK -mreCD (IU3890) were grown and transformed as described in Materials and Methods. An equal amount (100 ng) of linear double-stranded DNA amplicon was used for each transformation. Transformation reactions and the plating of IU2920 and IU3890 were performed in the presence of 0.8% (wt/vol) fucose. Numbers of transformants were scored after 14 to 18 h of incubation for strains other than D39 ⌬cps, which was incubated for at least 24 h. The experiments were performed at least three times independently with similar results.
b NT, not tested.
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on October 15, 2017 by guest http://jb.asm.org/ ence or absence of fucose, respectively, compared to the expression of the R6 parent (see Tables S3 and S4 in the supplemental material). The transformation of the ⌬mreC, ⌬mreD, and ⌬mreCD amplicons into the R6 strain ectopically expressing MreCD (with fucose) was indistinguishable from the transformation of the parent R6 strain (Table 1 , rows 1, 4, 5, and 6). Recovered ⌬mreCD mutants in the ectopic expression strain were maintained in the presence of fucose to prevent the selection of suppressor mutations in response to MreCD loss. The removal of fucose resulted in the same growth properties as those in the presence of fucose (Fig. 3B) . We conclude that MreCD are not essential in laboratory strain R6 and that the lack of MreCD does not appreciably affect growth ( Fig. 3A and B) or cell morphology (Fig. 3C ) in the R6 background.
MreC and MreD are essential in the strain D39 genetic background and are required for normal cell shape. In contrast to laboratory strain R6, the transformation of ⌬mreC, ⌬mreD, and ⌬mreCD amplicons into an unencapsulated isogenic derivative (IU1945) of serotype 2 strain D39 yielded few colonies (Ͻ20) of diverse sizes only after longer (Ͼ24-h) incubation (Table 1 , rows 1, 4, 5, and 6). Transformations with control amplicons again yielded large numbers of colonies overnight (Table 1, rows 2, 3, and 7) . The same patterns of transformation were observed in encapsulated strain D39 and derivatives, indicating that capsule did not play a role in the low rate of recovery of ⌬mreC, ⌬mreD, and ⌬mreCD mutants (see below and data not shown). The appearance of relatively low numbers of colonies of variable sizes after longer incubation is a hallmark of suppressor mutation accumulation (1, 49) .
To test this idea and the essentiality of MreCD in the D39 background, we transformed the ⌬mreC, ⌬mreD, and ⌬mreCD amplicons into the merodiploid strain expressing an extra copy of mreCD ϩ from an ectopic site (Table 1 , rows 1, 4, 5, and 6). This time, the ⌬mreCD mutant amplicons readily transformed the merodiploid strain, producing uniform-sized colonies in 16 to 18 h, similarly to those in the control transformations (Table  1, rows 2, 3, and 7) . The D39 ⌬cps ⌬mreCD (or ⌬mreC or ⌬mreD)//P fcsK -mreCD ϩ merodiploid strains grew in the presence of 0.8% (vol/vol) fucose like the D39 ⌬cps mreCD ϩ parent, and the merodiploid cells appeared as typical diplococci with equatorial and septal staining by fluorescent vancomycin (FL-V) ( Fig. 4 ; also see Fig. S3 and S4 in the supplemental material), which binds to PG pentapeptides in regions of active PG biosynthesis (1, 2, 42, 46, 47) .
In contrast, merodiploid mutants depleted of MreC, MreD, and MreCD by shifting to medium lacking fucose abruptly stopped growing after Ϸ4 h, after which cell lysis occurred ( Fig.  4 ; also see Fig. S3 and S4 in the supplemental material). At 3 h after the shift, cells depleted for MreCD (or MreC or MreD) formed chains of nearly spherical cells that stained with FL-V primarily at equators but not at septa (Fig. 4 ; also see Table S1 in the supplemental material) grown in the presence or absence of fucose as described in Materials and Methods. IU2920 and IU2922 were maintained in the presence of fucose at all stages of the strain construction and storage and were deprived of fucose only in growth experiments. Null mutations in pbp1a suppress the requirement for pneumococcal mreCD in strain D39. We tested the hypothesis that suppressor mutations were accumulating in ⌬mreCD mutants by performing Illumina sequencing of the genomes of independent isolates that arose in transformations of strain D39 ⌬cps with the ⌬mreCDϽϾP c -erm amplicon (Table 1 , row 1). We confirmed that the isolates contained the ⌬mreCDϽϾP c -erm mutation and lacked a second copy of mreCD ϩ that might have arisen by gene duplication (52) . Suppressor mutations were mapped by costeffective whole-genome sequencing (see Materials and Methods). Besides the ⌬mreCDϽϾP c -erm insertion, each isolate contained two point mutations of the D39 mreCD ϩ ⌬cps parent (Table 2) . We focused on the pbp1a (Asp92Gly) mutation in isolate IU3897 ( Table 2 , row 1), because PBP1a is a prominent pneumococcal class A PG synthesis enzyme (see Introduction). The other suppressor isolate (IU3898) contained mutations in two genes of unknown function (Table 2 , rows 3 and 4), which were not characterized further in this study. a IU3897 and IU3898 were isolated from the small number of colonies that arose following independent transformations of unencapsulated D39 ⌬cps strain IU1945 with the ⌬mreCDϽϾP c -erm amplicon as described for Table 1 . Illumina whole-genome sequencing was performed as described in Materials and Methods. Besides the ⌬mreCDϽϾP c -erm insertion, the mutational changes shown are compared to the sequence of the IU1945 parent.
b The sequence determination of IU3897 contained a single, unresolved 43-bp gap (bp 1834486 to 1834528) in spd_1849 (putative SpoIIIJ-associated protein). Other results showed that the pbp1a (Asp92Gly) mutation was sufficient to allow growth of the ⌬mreCD mutant (see Table 3 ), so the sequencing gap was not filled in.
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We moved the pbp1a (Asp92Gly) allele into a fresh encapsulated D39 background as described in Materials and Methods (Table 3 ; also see Table S1 in the supplemental material). DNA sequencing confirmed that the resulting D39 rpsL1 pbp1a (Asp92Gly) mutant lacked the spd_1108 (Gly274Ser) mutation that also was present in the starting suppressed strain IU3897 ( Table 2 , row 2). Strikingly, ⌬mreCD, ⌬mreC, or ⌬mreD amplicons more readily transformed the constructed pbp1a (Asp92Gly) mutant than its isogenic pbp1a ϩ parent (Table 3, rows 1, 4, 5, and 6). pbp1a (Asp92Gly) mutant cells lacked overt shape defects and were in somewhat shorter chains than those of the encapsulated D39 rpsL1 parent (Fig.  5A) . pbp1a (Asp92Gly) ⌬mreCD (or ⌬mreC or ⌬mreD) mutant cells formed chains containing some aberrantly shaped cells compared to the shapes of pbp1a (Asp92Gly) mutant cells (Fig.  5A, arrows) . These results indicate that the pbp1a (Asp92Gly) mutation is sufficient to suppress the lethality caused by the absence of MreC and MreD, although cell division is not entirely normal in the suppressed mutants.
The PBP1a (Asp92Gly) amino acid change is in the N-terminal transglycosylase (TG) domain, and some amino acid changes in the TG domain of PBP1a lead to the inactivation of both the transglycosylase and transpeptidase activities (59) . We were unable to cross a ⌬pbp2a mutation into the pbp1a (Asp92Gly) mutant, confirming that the pbp1a (Asp92Gly) allele is a null mutation (data not shown). Consistent with this conclusion, a ⌬pbp1a deletion mutation also acted as a suppressor that abrogated the requirement for MreC and MreD in the D39 background (Table 4 , rows 1, 4, and 5). We performed these studies in the unencapsulated D39 ⌬cps rpsL ϩ background, because the presence of capsule masks or alters some cell division defects in S. pneumoniae D39 strains (1, 2). D39 ⌬pbp1a ⌬cps mutants grew like the D39 pbp1a ϩ ⌬cps parent (data not shown) and formed diplococci that stained normally with FL-V (Fig. 5B ), but unexpectedly they had significantly a The pbp1a (Asp92Gly) allele was moved to encapsulated strain IU1781 (D39 rpsL1) to give strain IU4418 ͓D39 rpsL1 pbp1a (Asp92Gly)͔ (see Table S1 in the supplemental material). IU1781 and IU4418 were transformed as described in Materials and Methods and footnote a of Table 1 .
FIG. 5. Suppression of the requirement for MreC and MreD in the D39
genetic background by the pbp1a (Aps92Gly) point mutation (A) or by a ⌬pbp1a deletion (B). The pbp1a (Asp92Gly) mutation was selected as a spontaneous suppressor (Table 2) and then moved into a clean genetic background (Table 3 ; also see Table S1 in the supplemental material). Phase-contrast micrographs (A and B, top row) and fluorescent micrographs of cells stained with FL-V (bottom row of B) were taken as described in Materials and Methods for cells growing exponentially. Isogenic sets of strains containing the indicated mutations were constructed in the encapsulated IU1781 or unencapsulated IU1945 parent strain (see Table S1 ) and are shown. Representative micrographs are shown for each strain, and arrows mark some defective cells of the ⌬mreC, ⌬mreD, or ⌬mreCD mutants. Bars indicate 2 m. The experiment represented in panel A or B was performed twice or at least three times, respectively, with similar results.
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reduced widths and lengths compared to their parent, resulting in smaller cells with increased average aspect ratios (Fig. 6 ).
The phenotypes of the ⌬pbp1a mutants were not caused by polarity, because pbp1a is transcribed oppositely to the next downstream gene (spd_0335), and the intercistronic region, including a putative factor-independent terminator, was maintained between pbp1a and spd_0335 in ⌬pbp1a mutations (see Table S1 in the supplemental material). In addition, a D39 pbp1a (Asp92Gly) ⌬cps mutant, which contains a nonpolar, single-base-pair change that inactivates PBP1a (Table 2) , formed the same narrower and shorter cells as the D39 ⌬pbp1a ⌬cps mutant compared to the cells of the D39 pbp1a ϩ ⌬cps parent (data not shown).
In contrast to the ⌬pbp1a mutant, ⌬pbp1a ⌬mreCD (or ⌬mreC or ⌬mreD) mutants formed short chains of cells containing misshaped cells, some of which stained aberrantly with FL-V. Like the pbp1a (Asp92Gly) mutation, the ⌬pbp1a deletion was sufficient to allow the growth of cells lacking MreC and MreD, although cell division was not fully restored. The formation of chains by unencapsulated pneumococcal strains is a common phenotype that we have observed for several mutants deficient in PG biosynthesis, including pcsB, ⌬pmp23, and ⌬dacA mutants (1, 2) . Finally, mutants lacking the other two class A PBPs (PBP2a and PBP1B) did not suppress the requirement for MreC and MreD (Table 4 ) and formed cells of dimensions similar to those of the pbp2a ϩ pbp1b ϩ parent strain (Fig. 6) . Thus, the suppression of lethality of ⌬mreCD mutations was confined to the absence of PBP1A among the class A PBPs.
We tested whether an allele difference in pbp1a underlies the requirement for MreC and MreD in strain D39 but not in laboratory strain R6. Among the many mutations acquired by R6, R6 protein Pbpla (Pbp1a R6 ) contains two amino acid differences (Ala124 instead of Thr and Gln388 instead of Asp) compared to its D39 progenitor (30) or other serotype strains, such as TIGR4 (60) . We reconstructed pbp1a R6 in the R6 background and swapped it into a D39 cps ϩ rpsL1 strain. Conversely, we reconstructed the pbp1a gene of strain D39 (pbp1a D39 ) in D39 cps ϩ rpsL1 and swapped it into the R6 background (Table 5 ; also see Table S1 in the supplemental material). The ⌬mreCD amplicon again readily transformed a D39 ⌬cps (IU945), D39 ⌬cps ⌬pbp1a::kan-rpsL ϩ (K164), D39 ⌬cps ⌬pbp2a::kan-rpsL ϩ (K166), and D39 ⌬cps ⌬ pbp1b::kan-rpsL (K180) were transformed as described in Materials and Methods and footnote a of Table 1 .
FIG. 6. ⌬pbp1a mutants are shorter and narrower than their unencapsulated D39 parent or deletion mutants lacking the other two class A PBPs (PBP1b or PBP2a). The indicated strains were grown exponentially, phase-contrast micrographs were taken, and cell dimensions were measured as described in Materials and Methods. Measurements were confined to single cells in diplococci in later stages of division, where separation points were clearly visible, and only one cell in each diplococcus was measured. Standard errors of the means are indicated, and P values were determined relative to the parent strain by unpaired t tests using GraphPad Prism software. Bars indicate 2 m. The experiment was performed three times. Table S1 in the supplemental material).
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on October 15, 2017 by guest http://jb.asm.org/ the reconstructed R6 strain pbp1a R6 but showed low transformation efficiency of the R6 strain containing the pbp1a D39 allele along with suppressor accumulation (Table 5 , row 1). We conclude that the pbp1a R6 allele was required for the suppression of the requirement for MreC and MreD in the R6 genetic background. However, the converse was less clear in the D39 background, where the pbp1a R6 allele led to more transformants than the reconstructed pbp1a D39 allele (Table 5 , row 1) but not nearly as many as for the control amplicon (Table 5 , row 2) or in the R6 background. Taken together, these results suggest that the pbp1a R6 allele and other mutations in the R6 background are required for the strong suppression of mreCD essentiality.
MreC is an abundant protein in S. pneumoniae. As anticipated from its homologues in other bacterial species (27, 32) , pneumococcal MreC fractionated with cell membranes (L.-T. Sham, unpublished). We quantified the amount of cellular MreC in laboratory strain R6 growing exponentially in BHI broth as described in Materials and Methods. Purified, soluble His 6 -(N ⌬32 amino acids)-MreCЈ, lacking its N-terminal membrane anchor, was used as a standard (1) . Known concentrations of protein were spiked into extracts of an R6 ⌬mreCD strain to generate a linear standard curve (see Fig. S5 in the supplemental material) in Western blots using anti-MreC polyclonal antibody. Amounts of MreC in comparable amounts of extracts of the R6 mreC ϩ parent strain were determined from the standard curve and converted to monomers per cell as described in Materials and Methods. This analysis showed that strain R6 cells contained Ϸ17,000 monomers (8,500 dimers) of MreC, indicating that MreC is a relatively abundant protein is S. pneumoniae.
MreC localizes to the equators and septa of dividing S. pneumoniae cells independently of MreD. In rod-shaped cells, MreC forms filamentous lateral spirals and localizes to paraseptal rings at division septa (see Introduction) (15, 31, 67) . The localization of MreC and MreD in ovococcus bacteria has never been reported. To localize MreC and MreD, we performed IFM as described in Materials and Methods. Initial attempts to localize MreC with anti-MreC polyclonal antibody did not yield a signal. Therefore, we used the approach of epitope tagging MreC and MreD with a peptide linker followed by three tandem copies of FLAG (L-FLAG 3 ), which has worked well in locating other essential pneumococcal proteins by IFM (2, 69). We constructed unencapsulated R6 and D39 ⌬cps strains expressing MreC-(C)-L-FLAG 3 from the native mreCD locus in the chromosome (Fig. 7) or under the control of the P fcsK promoter in the ectopic bgaA site (see Table S1 in the supplemental material). We used unencapsulated strains for these studies, because capsule often masks cell division defects of mutants (1, 2) . Growth, cell division, and cell shape were normal in D39 strains expressing MreC-L-FLAG 3 from its chromosomal locus, indicating that the fusion did not significantly impair MreC or MreD functions (data not shown). We binned images of diplococci at different stages of division before observing fluorescence (Fig. 7) .
In IFM, MreC-L-FLAG 3 located specifically to regions of PG synthesis at midcells, equators, and septa (Fig. 7) . The same patterns were observed in unencapsulated R6 and D39 expressing MreC-L-FLAG 3 from its native locus ( Fig. 7 and data not shown) or an ectopic site in the presence of 0.8% (wt/vol) fucose in R6 mreC ϩ //P fcsK -mreC-L-FLAG 3 merodiploid strains (data not shown). In control experiments, no fluorescence was observed in the isogenic parent strains lacking the MreC-L-FLAG 3 construct or in merodiploid strains in the absence of fucose (data not shown), and only a single band corresponding to the expected molecular mass was detected on Western blots probed with anti-FLAG antibody of extracts of strains expressing MreC-L-FLAG 3 (data not shown). Notably, the tight localization of MreC-L-FLAG 3 to equators and septa closely matched the staining pattern of FL-V at different stages of cell division (Fig. 5B) (2, 42) .
In the R6 background where MreD is not required (Table  1) , we found that the tight localization of MreC-L-FLAG 3 was not affected by a ⌬mreD mutation (data not shown). This result suggests that MreC does not require MreD for localization in the R6 genetic background. We also localized MreD-L-FLAG 3 in an unencapsulated D39 derivative (Fig. 8) . The MreD-L-FLAG 3 fusion expressed from its chromosomal locus again did not affect growth or cell division in the D39 background (compare Fig. 5B to 8) and gave a single band on Western blots probed with anti-FLAG antibody (data not shown). Similarly to MreC-L-FLAG 3 , MreD-L-FLAG 3 localized primarily to sites of PG synthesis at the equators and septa of dividing cells (Fig. 8) . However, MreD-L-FLAG 3 was more dispersed than MreC-L-FLAG 3 , and about half of the cells with labeling at equators, septa, or both places had MreD-L-FLAG 3 located elsewhere in the cells (Fig. 8, second and third rows) . These   FIG. 7 . MreC Spn -L-FLAG 3 localizes to the equators and septa of dividing pneumococcal cells. The upper diagram shows the chromosomal location of the L-FLAG 3 epitope tag fused to the carboxyl terminus of MreC. The indicated P c -erm cassette was used to select for the fusion construction in unencapsulated R6 and D39 background strains (see Table S1 in the supplemental material). The P c -erm insertion did not cause any defects in growth or cell division in the D39 background, where MreC and MreD are essential ( Fig. 4 ; also see ⌬mreCD mutations exacerbate pcsB phenotypes in laboratory strain R6. Given the conserved proximity of mreCD and pcsB in the pneumococcal chromosome and their roles in cell division (1, 2, 19, 42) , we examined whether there was a functional relationship between mreCD and pcsB in the R6 genetic background. The mreCD ϩ pcsB ϩ //P c -pcsB ϩ merodiploid strain, which has a constitutively expressed ectopic copy of pcsB ϩ , expresses about 30% more PcsB than the R6 parent strain (1) . Both the R6 mreCD ϩ pcsB ϩ //P c -pcsB ϩ and R6 ⌬mreCD pcsB ϩ //P c -pcsB ϩ strains had similar cell morphology and staining patterns with FL-V (Fig. 9A ) and showed similar sensitivity to penicillin G (Fig. 9B) . Previous experiments showed that the absence of MreCD did not alter the cellular amount of PcsB protein (1) . The underexpression of PcsB in the R6 mreCD ϩ ⌬pcsB//P c -pcsB ϩ strain to about 30% of its wild-type level resulted in slower growth (data not shown), chaining, cell compression to a more spherical shape, and prominent staining of equators with FL-V, but the increase in sensitivity to penicillin was marginal at most ( ingly, the lack of MreCD combined with the underexpression of PcsB in R6 ⌬mreCD ⌬pcsB//P c -pcsB ϩ led to slow growth and cell yield (data not shown), extended chaining, severe cell compression, aberrant staining patterns with FL-V, and extreme sensitivity to penicillin (Fig. 9) . Control complementation experiments showed that the severe phenotypes of R6 ⌬mreCD ⌬pcsB//P c -pcsB ϩ were reversed by expressing MreCD or PcsB from controlled promoters or another ectopic site (data not shown). Thus, although not essential in the R6 genetic background, the lack of MreC and MreD exacerbates cell division defects caused by the depletion of certain other essential proteins.
DISCUSSION
We report here the first characterization of the MreC and MreD cell division proteins in an ovococcus species. MreC and MreD from S. pneumoniae have several remarkable features compared to their homologues in rod-shaped bacterial species (3, 15, 27, 31, 32) . Like MreC in E. coli and B. subtilis (27, 62) , pneumococcal S. pneumoniae MreC (MreC Spn ) is an abundant membrane-bound protein of about 8,500 dimers per cell (see Fig. S5 in the supplemental material). Like MreC and MreD from rod-shaped bacteria, MreC Spn and MreD Spn are localized to areas of active PG synthesis that correlate to staining with FL-V ( Fig. 7 and 8) . However, unlike rod-shaped bacteria that organize lateral wall PG synthesis into spiral filaments, MreC Spn and MreD Spn localize to pneumococcal equators and septa. MreC Spn localization was confined to these division sites at all stages of division (Fig. 7) , and MreC Spn still localized normally in the absence of MreD Spn in a ⌬mreD mutant of laboratory strain R6 (see Results). In contrast, MreD Spn localized to equators and septa but also was detected at other sites in about half of the cells (Fig. 8) . Taken together, these results suggest that MreC Spn and MreD Spn have different dynamics and independent assembly during pneumococcal cell division, analogous to the formation of the paraseptal rings in E. coli (67, 68) . We were unable to detect any filament formation of MreC Spn and MreD Spn by this method, in contrast to the tight localization detected for MreC Spn at the equators and septa of dividing cells (Fig. 7) . Although we cannot rule out weak filament formation by MreC Spn , these results suggest that filament formation is not an intrinsic property of MreC Spn , as was assumed in interpreting the structure of the carboxyl-terminal coiledcoil domain of MreC Spn (34) .
Like rod-shaped bacteria, MreC Spn and MreD Spn are essential for pneumococcal growth in prototypical virulent serotype 2 strain D39 and its unencapsulated derivatives (Tables 1 and  3 and Fig. 4 ; also see Fig. S3 and S4 in the supplemental material). Consistent with this conclusion, mreC and mreD could not be knocked out in serotype 4 strain TIGR4 by transposon mutagenesis (63) . The depletion of MreCD, MreC, or MreD caused cells to stop growing, become spherical, form chains, and lyse ( Fig. 4 ; also see Fig. S3 and S4 ). As cells became spherical, aberrant patterns of staining with FL-V appeared. In contrast, MreC Spn and MreD Spn were not essential for the growth of laboratory strain R6 (Table 1 and Fig. 3 ), which contains numerous mutational changes from its D39 progenitor strain (30) . This difference in essentiality for mreCD between D39 and TIGR4 versus R6 strains likely is due to the accumulation of suppressor mutations, which can be readily selected in D39 ⌬mreCD mutants (Tables 1 and 2 ). Whole-cell genome sequencing of two independent ⌬mreCD suppressor mutants uncovered a new genetic relationship between PBP1a and MreCD in S. pneumoniae, which was analyzed further in this study (Tables 3 to 5 ). In addition, sequencing revealed that the suppression of mreCD essentiality can occur by at least one mechanism other than mutations in pbp1a ( Table 2 , rows 3 and 4). This second mechanism involves mutations in one or two genes (spd_0177 and spd_1346) encoding hypothetical proteins of unknown functions. Based on precedents from E. coli (3), the identification and characterization of these and additional ⌬mreCD bypass suppressor mutations likely will increase the understanding of PG synthesis in S. pneumoniae and other species.
Amino acid changes that inactivated PBP1a, such as Asp92Gly, and the absence of PBP1a suppressed the requirement for MreC and MreD in the D39 background (Tables 3  and 4 and Fig. 5 ). Thus, MreC and MreD are required for the growth of D39 strains when PBP1a is functional but are not required when PBP1a is inactivated or absent. However, the amino acid changes in PBP1a R6 were not sufficient to account fully for the nonessentiality of mreCD in strain R6 compared to its importance in D39 ( Table 5 ), suggesting that other mutations in the R6 background contribute to the suppression of the ⌬mreCD requirement. On the other hand, swapping the pbp1a D39 and pbp1a R6 alleles in strain R6 restored the requirement for MreC and MreD in the R6 background (Table 5) , which is consistent with the conclusion that there is a reinforcing genetic link between pbp1a and mreCD in S. pneumoniae.
PBP1a is a major class A bifunctional enzyme and the only pneumococcal class A enzyme implicated in the development of high levels of ␤-lactam resistance (10, 39, 56) . Unlike PBP1a, the absence of the other pneumococcal class A enzymes, PBP2a and PBP1b, did not relieve the requirement for MreC and MreD (Table 4 ). PBP1a and PBP2a show a synthetic lethal relationship, in that pbp1a pbp2a double mutants are not viable (24, 45) . However, the different suppression properties of ⌬pbp1a and ⌬pbp2a mutants (Table 4) indicate that this synthetic lethality is not due to simple functional redundancy. Consistent with this interpretation, we observed that the ⌬pbp1a deletion markedly reduced cell size and increased aspect ratios by reducing cell diameters of an unencapsulated derivative of D39 (Fig. 6) . In contrast, ⌬pbp2a or ⌬pbp1b mutations did not significantly change cell dimensions (Fig. 6) . The reduction in cell size caused by ⌬pbp1a was more apparent in the unencapsulated than in encapsulated D39 strains (compare Fig. 5A to 6 ), probably because of the tendency of the pneumococcal capsule to mask or alter cell division defects (1, 2) . The smaller size of ⌬pbp1a mutants compared to that of the parent was not observed previously in the R6 background (24, 45) , possibly due to the numerous differences in PG biosynthesis between the R6 and D39 genetic backgrounds, including the suppression of ⌬mreCD deletions reported here and the significantly different PG peptide crossbridge composition reported previously (1) .
The phenotypes discussed above support a role for MreC, MreD, and PBP1a in peripheral PG synthesis (Fig. 1) . Our current working model is that the pneumococcal peripheral PG synthesis complex contains MreC, MreD, and PBP1a, along with several other proteins suggested by previous work in pneumococcus and other bacteria, including class B PBP2b Spn , RodA Spn , shuttle protein GpsB Spn , and another pneumococcal class A enzyme (see Introduction) (9, 46, 72) . According to this model, the depletion of MreC, MreD, or both would decrease peripheral PG synthesis and lead to spherical cell formation ( Fig. 4 ; also see Fig. S3 and S4 in the supplemental material) (31, 46) . The marked reduction in width of ⌬pbp1a mutant cells (Fig. 6 ) is also consistent with reduced peripheral PG synthesis, which has been implicated in setting bacterial cell diameters by a mechanism that is largely unknown (9, 41, 71) . The unusual genetic relationship reported here between MreCD and PBP1a (Tables 1, 3 , and 4) would result if MreC and MreD are required for correct PBP1a localization, activity, or both in peripheral PG synthesis. The depletion of MreCD would not only diminish peripheral PG synthesis but also lead to aberrant PBP1a localization and activity that causes rapid cell lysis (Fig. 4) . For example, PBP1a may shuttle between peripheral and septal PG synthesis, as has been proposed for its PBP1 homologue in B. subtilis (9, 26) . The absence of S. pneumoniae MreCD (MreCD Spn ) may disrupt this process such that the absence of PBP1a obviates the requirement for MreC and MreD. Thus, mreCD Spn are genetically essential, whereas pbp1a Spn is not, but aberrant Pbp1a localization, activity, or both may underlie the lethality of mreCD Spn mutations.
A somewhat parallel genetic relationship was observed in B. subtilis, where the inactivation of PBP1 suppressed the requirement for the MreB homologue (26) . The deleterious mislocalization of PBP1 in the absence of MreB was invoked to explain this genetic relationship, and it was suspected that MreC, which interacts with MreB and PBP1 in B. subtilis, also is involved in the proper localization of PBP1 (26) . In S. pneumoniae, the viable ⌬pbp1a ⌬mreCD mutants form chains containing some cells with division defects (Fig. 5) , implying that the remaining class A PBPs can carry out division sufficiently to allow remarkably normal growth. Aspects of this working model currently are being tested. Preliminary experiments indicate that other proteins that may mediate pneumococcal peripheral PG synthesis are essential for growth, including RodA Spn and GpsB Spn , in the presence or absence of PBP1a Spn (data not shown). The abundance, essentiality, and surface location of conserved PG synthesis complex proteins like MreC suggest that they could be potential targets fot the development of pneumococcal vaccines.
Curiously, MreC and MreD are present in coccus species, such as S. aureus, that encode a single class A PBP and are not thought to carry out peripheral PG synthesis (57, 72) . Notably, the mreCD genes are not essential in S. aureus (7), unlike in ovococcus S. pneumoniae (Table 1 and Fig. 4 ; also see Fig. S3 and S4 in the supplemental material). Conversely, MreC and MreD are absent from some ovococcus species, especially in the pyogenic group that includes S. pyogenes and S. agalactiae (35, 72) . This absence raises the question of whether proteins other than MreC and MreD homologues organize peripheral PG synthesis in these species. There are several differences in the composition of the PG biosynthetic apparatus between these species and S. pneumoniae. For example, S. pneumoniae encodes a single low-molecular-weight D,D-carboxypeptidase PBP (DacA), whereas S. pyogenes and S. agalactiae encode several low-molecular-weight PBPs (35, 72) . The modification of PG precursor substrates by low-molecular-weight PBPs has been implicated in localizing the PG synthetic apparatus (2, 8, 38, 40, 48) .
Although MreC and MreD also are not required in the pneumococcus R6 genetic background (Tables 1 and 5 and Fig. 3), their absence still greatly exaggerated the cell division defects caused by the underexpression of the PcsB protein (Fig.  9 ). When present in ovococcus species, mreCD are always located upstream from pcsB, which is regulated by the Wal-RK Spn (VicRK) two-component system from the P pcsB promoter between mreCD and pcsB (Fig. 2) (1, 42, 43) . We could detect a mreCD-pcsB cotranscript by sensitive RT-PCR methods (see Fig. S2 in the supplemental material), but the relative amount and significance, if any, of this cotranscript remain unknown for two reasons. First, there is considerable independent transcription of pcsB from the WalR Spn -dependent P pcsB promoter (Fig. 2) , which is consistent with previous results from expression experiments (43) . Second, despite the abundance of MreC, we were unable to detect an mreC transcript on Northern blots (see Results). This negative result could mean that the mreCD transcript is unstable or that mreCD is contained in a long transcript that did not transfer well. The latter interpretation is suggested by recent tiling array analyses indicating that mreCD are the last two genes in a nine-gene cotranscript that does not extend into pcsB (29) .
Monocistronic expression was previously reported for gbpB Smu , which is the pcsB homologue in S. mutans (37) . Recently, it was proposed that GbpB Smu is not a cell division protein at all but rather coordinates exopolysaccharide biofilm formation with cell growth and surface biogenesis (14) . It is difficult to reconcile the exaggeration of division defects caused by PcsB underexpression in ⌬mreCD mutants with this model, especially since the R6 strain does not produce the capsule exopolysaccharide, which is the only one known to be produced by D39-derived pneumococcal strains. New results to be reported elsewhere show that PcsB interacts with an essential membrane-bound cell division protein that may control the PG hydrolytic activity of PcsB (L.-T. Sham, unpublished).
